As the issue of the Covid-19 vaccine remains divided and more people seek factual information here are the two sides of the side effects of the Covid vaccine according to the CDC (Center for Disease Control).
On the CDC website, there are two pages concerning the side effects of the vaccine.
The first page and the easiest page to find list the common side effects of getting the vaccine, which is the same as getting any flu shot.
On the arm where you got the shot:
Throughout the rest of your body:
- Muscle pain
The CDC does warn that if you had a severe or immediate reaction to the first dose of an mRNA Covid 19 vaccine, you should not get a second dose of either of the mRNA Covid 19 vaccines.
They also state and remind individuals that if you get Pfizer-BioNTech and the Moderna vaccines you will be required to get two shots. But if you get the Johnson & Johnson’s Janssen Covid 19 shot you will require only 1 dose.
The More Severe Side Effects
On the second CDC website page which is a bit more difficult to find and written in more technical language is a list of the more severe side effects of getting the vaccine.
They begin on this page by explaining that all adverse effects described on the page are reported through the Vaccine Adverse Event Reporting System (VAERS).
These Effects Are:
- Anaphylaxis after COVID-19 vaccination is rare and has occurred in approximately 2 to 5 people per million vaccinated in the United States. Severe allergic reactions, including anaphylaxis, can occur after any vaccination. If this occurs, vaccination providers can effectively and immediately treat the reaction. Learn more about COVID-19 vaccines and allergic reactions, including anaphylaxis.
- Thrombosis with thrombocytopenia syndrome (TTS) after Johnson & Johnson’s Janssen (J&J/Janssen) COVID-19 vaccination is rare. As of July 26, 2021, more than 13 million doses of the J&J/Janssen COVID-19 Vaccine have been given in the United States. CDC and FDA identified 39 confirmed reports of people who got the J&J/Janssen COVID-19 Vaccine and later developed TTS. Women younger than 50 years old especially should be aware of the rare but increased risk of this adverse event. There are other COVID-19 vaccine options available for which this risk has not been seen. Learn more about J&J/Janssen COVID-19 Vaccine and TTS.
- To date, two confirmed cases of TTS following mRNA COVID-19 vaccination (Moderna) have been reported to VAERS after more than 328 million doses of mRNA COVID-19 vaccines administered in the United States. Based on available data, there is not an increased risk for TTS after mRNA COVID-19 vaccination.
- CDC and FDA are monitoring reports of Guillain-Barré Syndrome (GBS) in people who have received the J&J/Janssen COVID-19 Vaccine. GBS is a rare disorder where the body’s immune system damages nerve cells, causing muscle weakness and sometimes paralysis. Most people fully recover from GBS, but some have permanent nerve damage. After more than 13 million J&J/Janssen COVID-19 Vaccine doses administered, there have been around 137 preliminary reports of GBS identified in VAERS as of July 22. These cases have largely been reported about 2 weeks after vaccination and mostly in men, many 50 years and older. CDC will continue to monitor for and evaluate reports of GBS occurring after COVID-19 vaccination and will share more information as it becomes available.
- Myocarditis and pericarditis after COVID-19 vaccination are rare. As of July 26, 2021, VAERS has received 1,194 reports of myocarditis or pericarditis among people ages 30 and younger who received COVID-19 vaccine. Most cases have been reported after mRNA COVID-19 vaccination (Pfizer-BioNTech or Moderna), particularly in male adolescents and young adults. Through follow-up, including medical record reviews, CDC and FDA have confirmed 699 reports of myocarditis or pericarditis. CDC and its partners are investigating these reports to assess whether there is a relationship to COVID-19 vaccination. Learn more about COVID-19 vaccines and myocarditis.
- Reports of death after COVID-19 vaccination are rare. More than 342 million doses of COVID-19 vaccines were administered in the United States from December 14, 2020, through July 26, 2021. During this time, VAERS received 6,340 reports of death (0.0019%) among people who received a COVID-19 vaccine. FDA requires healthcare providers to report any death after COVID-19 vaccination to VAERS, even if it’s unclear whether the vaccine was the cause. Reports of adverse events to VAERS following vaccination, including deaths, do not necessarily mean that a vaccine caused a health problem. A review of available clinical information, including death certificates, autopsy, and medical records, has not established a causal link to COVID-19 vaccines. However, recent reports indicate a plausible causal relationship between the J&J/Janssen COVID-19 Vaccine and TTS, a rare and serious adverse event—blood clots with low platelets—which has caused deaths.
It is important for anyone who is debating to get any vaccine to inform themselves fully prior to getting a vaccine.